top of page

56 million euros from national growth fund for RegMed XB and ReGEN Biomedical

9 apr. 2021

The Dutch cabinet decided to fully fund the National Growth Fund application of RegMed XB. A maximum of 56 million euros will be available for setting up four pilot plants for regenerative medicine, among which is ReGEN Biomedical!

The pilot factory makes it possible to make various materials (biomaterials, stem cells, micro tissues, macro tissues) on a larger scale. The new facilities in the four participating regions (Eindhoven, Leiden, Maastricht, Utrecht) together form the pilot factory. They cover the entire chain of development and small-scale production of biomaterials, stem cells, micro- and macro tissues for personalized applications.

Marianne van der Steen (CEO ReGEN Biomedical): "In Limburg, ReGEN Biomedical focuses on the assembly of micro-tissues to macro-tissues. Anyone can use the pilot plant, such as researchers, start-ups and scale-ups. This collaboration between four distinct pilot plants for regenerative solutions, in which all parties work together intensively, is unique in the world and of great value."

bottom of page